Healthtech funding in Q4 2014
European Healthtech startup funding raised during Q4 2014.
In Q4 2014, 36 European Healthtech companies closed 36 funding rounds and raised €297M in equity funding (excluding debt and grants), up 59.0% versus Q4 2013. UK led by capital raised, and Sofinnova Partners was the most active investor. Data as of 6 Nov 2026.
Equity funding
€297M
+59.0% vs Q4 2013 · excl. debt & grants
Funding rounds
36
+20.0% vs Q4 2013
Companies
36
Top country
UK
Rank among sectors
#3
10.8% of sector funding
Top-10 round share
77.3%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q4 2014 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Oct | €40M | 9 |
| Nov | €129M | 12 |
| Dec | €128M | 15 |
Top countries
by € raisedHealthtech — top countries by capital, Q4 2014 — interactive chart.
Data table
| Healthtech — top countries by capital, Q4 2014 | |
|---|---|
| UK | €118M |
| Denmark | €48M |
| Switzerland | €39M |
| Israel | €30M |
| Netherlands | €23M |
| Germany | €19M |
| France | €13M |
| Finland | €6.0M |
Stage mix
by € raisedHealthtech — stage mix, Q4 2014 — interactive chart.
Data table
| Healthtech — stage mix, Q4 2014 | |
|---|---|
| Series B | €137M |
| Series C | €48M |
| Other | €40M |
| Series A | €37M |
| Early VC | €32M |
| Seed | €2.9M |
Top deals
largest disclosed rounds in Q4 2014| Company | Stage | Date | Amount |
|---|---|---|---|
| Cell Medica | Series B | Nov 2014 | €64M |
| Ascendis Pharma | Series C | Dec 2014 | €48M |
| Quanta Fluid Solutions | Series B | Nov 2014 | €34M |
| Xeltis | Series B | Dec 2014 | €27M |
| Anergis | Series B | Dec 2014 | €12M |
| GI View | Other | Dec 2014 | €10M |
| Check-Cap | Other | Oct 2014 | €9.5M |
| Rigontec | Series A | Oct 2014 | €9.4M |
| RealView Imaging | Other | Dec 2014 | €8.0M |
| Alpha Mos | Early VC | Nov 2014 | €6.7M |
| Cristal Therapeutics | Early VC | Dec 2014 | €6.0M |
| Medigo | Series A | Dec 2014 | €5.0M |
| Epigenomics AG | Other | Oct 2014 | €4.8M |
| myTomorrows | Early VC | Nov 2014 | €4.5M |
| Creo Medical | Early VC | Nov 2014 | €4.5M |
Top investors
most active in Q4 2014, by deal count- Sofinnova Partners2 deals
- Thuja Capital2 deals
- Wellington Partners2 deals
- Accel1 deals
- AlbionVC1 deals
- Amadeus Capital Partners1 deals
- Angel CoFund1 deals
- Balderton Capital1 deals
- BioGeneration Ventures1 deals
- Boehringer Ingelheim Venture Fund1 deals